Group Mailing 2003-10-15

Priority Lists

Disease Committee	Last Changed
Breast Cancer	11/1/23
Cancer Care Delivery	9/1/22
Cancer Survivorship	1/14/19
comboMATCH	12/1/23
Early Therapeutics & Rare Cancers	12/1/23
Gastrointestinal Cancer	12/1/23
Genitourinary Cancer	12/1/23
Head and Neck Cancer	12/15/07
iMATCH	11/1/22
Immunomolecular Therapeutics	6/15/20
Leukemia	3/22/23
Lung Cancer	12/1/23
LungMAP	12/15/23
Lymphoma	1/17/24
Melanoma	4/18/22
Myeloma	4/1/24
Other	2/1/14
Prevention & Epidemiology	7/1/24
Symptom Control and Quality of Life	4/1/23

S0107Phase II

A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer

Study Coordinator(s)	Robert P. Whitehead, M.D.
Participants	Members, NCORP

S0108Phase II

Bevacizumab (rhuMAb) (NSC 704865) Therapy For Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma

Study Coordinator(s)	Alison T. Stopeck, M.D., Thomas P. Miller, M.D., Thomas M. Grogan, M.D., William T. Bellamy, R. Ph.
Participants	Members, NCORP, Medical Oncologists, Pathologists